Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quest Laboratories is an India-based commercial pharmaceutical manufacturing company focused on formulation development and production of a broad portfolio of generic and branded medicines. The company manufactures tablets, capsules, liquid orals, dry syrups, oral powders, ointments, external liquids, ampoules, and vial-based injectables, and it also undertakes contract manufacturing for other pharmaceutical companies. Its product coverage spans multiple therapy categories including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medicines, diabetes treatments, and antidepressants. Quest operates manufacturing facilities in Madhya Pradesh with WHO-GMP, GMP, and GLP credentials highlighted in company materials, and it expanded its profile through an NSE SME listing in 2024. Overall, it appears to be a revenue-generating, commercially active small-cap pharma formulations manufacturer rather than a clinical-stage biotech innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quest Laboratories.